Literature DB >> 6290595

Variation in murine cytomegalovirus replication in fibroblasts from different mouse strains in vitro: correlation with in vivo resistance.

G B Harnett, G R Shellam.   

Abstract

The in vitro growth of murine cytomegalovirus (MCMV) in mouse embryo fibroblasts (MEF) from Balb/c, C57BL, C3H and CBA mouse strains has been shown to correlate with the genetically determined in vivo susceptibility of these strains to MCMV infection. MEF from Balb/c and C57BL mice were more susceptible to MCMV than those from C3H and CBA mice. This was evident regardless of whether replication was measured by cytopathic effect (c.p.e.) score, virus yield, plaque count, plaque size or time of onset of c.p.e. The growth of MCMV in tracheal organ cultures from different mouse strains was similar to that observed in MEF from these strains. The replication in MEF when measured by c.p.e. score and virus yield was affected by the density of the cell cultures. The strain of mouse used to produce MCMV also affected the comparative sensitivity of MEF to the virus. This appeared to be due to reduced growth of MCMV in its homologous MEF type, an unexpected result. In contrast, cell density had little effect on the replication of herpes simplex virus type 1 (HSV-1), but again the in vitro susceptibility of MEF reflected the in vivo susceptibility of mouse strains to infection with this virus.

Entities:  

Mesh:

Year:  1982        PMID: 6290595     DOI: 10.1099/0022-1317-62-1-39

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.

Authors:  R Holtappels; J Podlech; G Geginat; H P Steffens; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

3.  Inflammatory and immunological responses to murine cytomegalovirus in resistant CBA mice.

Authors:  P Price; J G Winter; K S Eddy; G R Shellam
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 4.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Functional changes in murine macrophages infected with cytomegalovirus relate to H-2-determined sensitivity to infection.

Authors:  P Price; J G Winter; S Nikoletti; J B Hudson; G R Shellam
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

6.  Deficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins.

Authors:  Xuefang Xie; Abhijit Dighe; Patricia Clark; Pearl Sabastian; Sarah Buss; Michael G Brown
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro.

Authors:  J Chang; H M Naif; S Li; J S Sullivan; C M Randle; A L Cunningham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Genetically determined resistance to lethal murine cytomegalovirus infection is mediated by interferon-dependent and -independent restriction of virus replication.

Authors:  G V Quinnan; J F Manischewitz
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

9.  Genetically determined resistance to murine cytomegalovirus and herpes simplex virus in newborn mice.

Authors:  G R Shellam; J P Flexman
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

10.  Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection.

Authors:  M N Wykes; G R Shellam; J McCluskey; W M Kast; P B Dallas; P Price
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.